ENDLYZ THERAPEUTICS
ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias.
ENDLYZ THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Status:
Active
Total Funding:
3.25 M USD
Similar Organizations
Fiat Labs
Fiat Labs is currently operating in stealth mode.
Marlinspike Therapeutics
Marlinspike Therapeutics is a biotechnology company operating in stealth mode.
Route Line
Route Line is an end-to-end adventure company that provides access to beautifully outfitted, premium RVs, and Adventure vehicles.
Sanegene Bio
Sanegene Bio is currently operating in stealth mode.
More informations about "Endlyz Therapeutics"
Endlyz Therapeutics - Crunchbase Company Profile & Funding
NdLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other …See details»
EndLyz - Oxford Science Enterprises
EndLyz is an early stage biotech company developing disease-modifying therapeutics that restore endo-lysomsomal function to treat neurodegenerative disorders such as Parkinson’s Disease …See details»
AbbVie Ventures Portfolio | AbbVie - Pharmaceutical Research
Oct 24, 2024 · EndLyz Therapeutics is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and …See details»
Endlyz Therapeutics, Inc. – Dementia Discovery Fund
Dementia Discovery Fund (DDF)-founded EndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other …See details»
Endlyz Therapeutics - Funding, Financials, Valuation & Investors
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.See details»
EndLyz Therapeutics - VentureRadar
EndLyz Therapeutics is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias. …See details»
Endlyz Therapeutics - Products, Competitors, Financials, Employees ...
Endlyz Therapeutics operates as a biotechnology company. The company develops disease-modifying therapeutics to restore endo-lysosomal function and abrogate neurodegeneration in …See details»
EndLyz Therapeutics Inc - Oxford University Innovation
Contact Us. Oxford University Innovation Buxton Court 3 West Way Oxford OX2 0JB. T: +44 (0) 1865 280830 . E: [email protected]See details»
Angel Round - Endlyz Therapeutics - 2021-07-29 - Crunchbase
Jul 29, 2021 · Endlyz Therapeutics raised $3250000 on 2021-07-29 in Angel Round. Unlock even more features with Crunchbase ProSee details»
Harnessing the power of RNA epigenetics - STORM …
STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.See details»
Parkinson’s UK invests £185K in new company to develop …
Through its innovative Parkinson’s Virtual Biotech, Parkinson’s UK is investing £185,000 in EndLyz Therapeutics, Inc. (“EndLyz”). This new Dementia Discovery Fund (DDF)-founded …See details»
Further £220K to develop therapies targeting lysosomal dysfunction
Several other venture funds have joined in financing EndLyz and its project, which aims to develop disease-modifying therapeutics to restore lysosomal function and combat …See details»
Parkinson’s Virtual Biotech - Parkinson's Foundation
Overview: We’re working with EndLyz Therapeutics, Inc. to help find therapeutic ways to clear cells of damaging or unwanted materials that might contribute to the causes of Parkinson’s. …See details»
Endlyz Therapeutics - Updates, News, Events, Signals & Triggers
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.See details»
Endlyz Therapeutics Stock Price, Funding, Valuation, Revenue ...
Jul 29, 2021 · See Endlyz Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Endlyz Therapeutics's post-money valuation and revenue.See details»
Active projects - Parkinson's UK
We’re working with EndLyz Therapeutics, Inc. to help find therapeutic ways to clear cells of damaging or unwanted materials that might contribute to the causes of Parkinson’s. Recent …See details»
Endlyz Therapeutics - Crunchbase
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies. Endlyz Therapeutics is developing disease-modifying therapeutics for …See details»
Joanna Wolak Ph.D Profile: Contact Information & Network
Dr. Joanna Wolak is a Co-Founder and serves as Chief Scientific Officer & President at Endlyz Therapeutics. She served as Venture Partner at Dementia Discovery Fund. She serves as …See details»